YEAR
- 2007.03.14 Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges. Midorikawa Y, Makuuchi M, Tang W, Aburatani H.World J. Gastroenterol. 2007 Mar 14;13(10):1487-92. doi: 10.3748/wjg.v13.i10.1487
- 2007.04.09 Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H.Diabetes. 2007 Feb;56(2):363-72. doi: 10.2337/db06-0359
- 2007.11.28 Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophages. Imamura M, Kawasaki T, Savchenko AS, Ohashi R, Jiang S, Miyamoto K, Ito Y, Iwanari H, Sagara M, Tanaka T, Hamakubo T, Kodama T, Uchiyama M, Naito M.Cell. Immunol. 2007 Aug;248(2):86-94. doi: 10.1016/j.cellimm.2007.09.003
- 2007.10.06 Life style-related diseases of the digestive system: gene expression in nonalcoholic steatohepatitis patients and treatment strategies. Yoneda M, Endo H, Nozaki Y, Tomimoto A, Fujisawa T, Fujita K, Yoneda K, Takahashi H, Saito S, Iwasaki T, Yamamoto S, Tsutsumi S, Aburatani H, Wada K, Hotta K, Nakajima A.J. Pharmacol. Sci. 2007 Oct;105(2):151-6. doi: 10.1254/jphs.fm0070063
- 2007.06.05 Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells. Yamazaki H, Suzuki M, Aoki T, Morikawa S, Maejima T, Sato F, Sawanobori K, Kitahara M, Kodama T, Saito Y.J. Atheroscler. Thromb. 2006 Dec;13(6):295-307. doi: 10.5551/jat.13.295
- 2007.03.20 Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice. Yoshizumi S, Suzuki S, Hirai M, Hinokio Y, Yamada T, Yamada T, Tsunoda U, Aburatani H, Yamaguchi K, Miyagi T, Oka Y.Metab. Clin. Exp. 2007 Mar;56(3):420-9. doi: 10.1016/j.metabol.2006.10.027
- 2007.08.09 Identification of TSC-22 as a potential tumor suppressor that is upregulated by Flt3-D835V but not Flt3-ITD. Lu Y, Kitaura J, Oki T, Komeno Y, Ozaki K, Kiyono M, Kumagai H, Nakajima H, Nosaka T, Aburatani H, Kitamura T.Leukemia. 2007 Nov;21(11):2246-57. doi: 10.1038/sj.leu.2404883
- 2007.10.01 Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Morikawa T, Sugiyama A, Kume H, Ota S, Kashima T, Tomita K, Kitamura T, Kodama T, Fukayama M, Aburatani H.Clin. Cancer Res. 2007 Oct 01;13(19):5703-9. doi: 10.1158/1078-0432.CCR-07-0603
CLOSE